The Latest Breaking News from Pfizer

In this week’s newsletter: after days of bad tweets and red carpet reactions, here’s the last word on the biggest Oscars moment of the decade

According to a US-based study, children ages 5 to 11 who received the Pfizer Inc (NYSE:PFE) / BioNTech SE's (NASDAQ:BNTX) COVID-19 vaccine were 68% less likely to be hospitalized during the omicron wave than unvaccinated children. Adolescents aged 12-18 who received two shots of the vaccine were around 40% less likely to be hospitalized with the…

A UCLA professor’s long-term coexistence plan won’t help and could hinder Shanghai’s response to the current crisis, a Zhejiang University professor argues

When Covid-19 stalled the world's economic motor in early 2020, ICON CEO Steve Cutler and his team at the vaccine trials company revved up.

As governments prepare to live with COVID-19, some are questioning how much to rely on drugmakers to adapt vaccines to ward off future virus variants amid signs of tension between companies and regulators over the best approach, according to several sources familiar with the matter.

Pressure is increasing on the administration to go after drug patents.

The authorization for another booster arrives just as BA.2 becomes the dominant strain in the U.S.

Amid worst Covid-19 outbreak, city could turn pandemic into manageable endemic disease using self-isolation, self-testing and advanced drugs and vaccines

Washington (AFP) - President Joe Biden received a second Covid-19 vaccine booster shot Wednesday and urged Americans to keep their guard up, while declaring that the pandemic no longer dominates the country.

Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait

Washington (AFP) - President Joe Biden will receive a second Covid-19 vaccine booster shot on Wednesday, the White House said.